Imunon Inc (IMNN)
1.31
0.00 (0.00%)
USD |
NASDAQ |
May 02, 12:42
Imunon Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2006 | 25.23% |
| December 31, 2005 | 37.27% |
| September 30, 2005 | 31.79% |
| June 30, 2005 | 33.48% |
| March 31, 2005 | 31.99% |
| December 31, 2004 | 9.39% |
| September 30, 2004 | 19.17% |
| June 30, 2004 | 30.55% |
| March 31, 2004 | 32.93% |
| December 31, 2003 | |
| September 30, 2003 | |
| June 30, 2003 |
| Date | Value |
|---|---|
| March 31, 2003 | |
| December 31, 2002 | |
| September 30, 2002 | |
| June 30, 2002 | |
| March 31, 2002 | |
| December 31, 2001 | |
| September 30, 2001 | |
| June 30, 2001 | |
| March 31, 2001 | |
| December 31, 2000 | |
| September 30, 2000 | -23.62K% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Avalo Therapeutics Inc | -- |
| iBio Inc | -- |
| Ocugen Inc | -- |
| Petros Pharmaceuticals Inc | -- |
| Moderna Inc | 66.97% |